.Pharmacolibrary.Drugs.ATC.M.M01AB08

Information

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, osteoarthritis, and rheumatoid arthritis. It is commonly administered orally and is approved for medical use in many countries.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers after a single 200 mg oral dose.

References

1. Boni, J, et al., & Cooper, S (1999). Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. Journal of clinical pharmacology 39(7) 729–737. DOI:10.1177/00912709922008254 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10392328

2. Brater, DC, & Lasseter, KC (1989). Profile of etodolac: pharmacokinetic evaluation in special populations. Clinical rheumatology 8 Suppl 1 25–35. DOI:10.1007/BF02214107 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2525981

3. Benet, LZ (1994). Pharmacokinetic profile of etodolac in special populations. European journal of rheumatology and inflammation 14(1) 15–18. PUBMED:https://pubmed.ncbi.nlm.nih.gov/7744123

Revisions

• 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)